• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡洛尼技术在慢性完全闭塞经皮冠状动脉介入治疗中的应用。

Use of the Carlino Technique in Chronic Total Occlusion Percutaneous Coronary Intervention.

机构信息

Center of Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Department of Cardiology, Texas Health Presbyterian Hospital, Dallas, Texas.

出版信息

Am J Cardiol. 2023 Nov 15;207:305-313. doi: 10.1016/j.amjcard.2023.08.155. Epub 2023 Sep 28.

DOI:10.1016/j.amjcard.2023.08.155
PMID:37774471
Abstract

We examined the outcomes of the Carlino technique in chronic total occlusion (CTO) percutaneous coronary interventions (PCIs). We analyzed the baseline clinical and angiographic characteristics and outcomes of 128 CTO PCIs that included the Carlino technique at 22 US and no-US centers between 2016 and 2023. The Carlino technique was used in 128 (2.8%) of 4,508 cases that used anterograde dissection and reentry (78.9%) or the retrograde approach (21.1%) during the study period, and it increased steadily over time (from 0.0% in 2016 to 8.3% in 2023). The mean patient age was 65.6 ± 9.7 years, and 88.7% of the patients were men with high prevalence of hypertension (89.1%) and dyslipidemia (80.2%). The Carlino technique was more commonly used in cases with moderate to severe calcification (77.2% vs 55.5%, p <0.001) with higher J-CTO (3.3 ± 0.9 vs 3.0 ± 1.1, p = 0.007), Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO) (1.7 ± 1.0 vs 1.4 ± 1.0, p = 0.001), PROGRESS-CTO Mortality (2.6 ± 0.9 vs 2.0 ± 0.9, p = 0.013) and PROGRESS-CTO Perforation (3.7 ± 1.1 vs 3.5 ± 1.0, p = 0.029) scores. Carlino cases had longer procedure and fluoroscopy time, and higher contrast volume and radiation dose. Carlino cases had lower technical (65.6% vs 78.5%, p <0.001) and procedural (63.3% vs 76.3%, p <0.001) success, similar major adverse cardiac events (6.2% vs 3.2%, p = 0.101) and higher incidence of pericardiocentesis (3.9% vs 1.3%, p = 0.042), perforation (18.0% vs 8.9%, p = 0.001) and contrast-induced acute kidney injury (2.3% vs 0.4%, p = 0.012). The Carlino technique was associated with higher procedural success when used for retrograde crossing (81.5% vs 58.4%, p = 0.047). The Carlino technique is increasingly being used in CTO PCI especially for higher complexity lesions.

摘要

我们研究了 Carlino 技术在慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)中的结果。我们分析了 2016 年至 2023 年期间 22 个美国和非美国中心的 128 例 CTO PCI 中 Carlino 技术的基线临床和血管造影特征及结果。在研究期间,Carlino 技术在使用顺行夹层和再进入(78.9%)或逆行方法(21.1%)的 4508 例病例中的 128 例(2.8%)中使用,并且该技术的使用比例随着时间的推移而稳步增加(从 2016 年的 0.0%增加到 2023 年的 8.3%)。患者平均年龄为 65.6±9.7 岁,88.7%的患者为男性,高血压(89.1%)和血脂异常(80.2%)的患病率较高。Carlino 技术更常用于中度至重度钙化的病例(77.2%比 55.5%,p<0.001),J-CTO 评分更高(3.3±0.9 比 3.0±1.1,p=0.007),全球前瞻性慢性完全闭塞介入研究登记处(PROGRESS-CTO)评分(1.7±1.0 比 1.4±1.0,p=0.001),PROGRESS-CTO 死亡率(2.6±0.9 比 2.0±0.9,p=0.013)和 PROGRESS-CTO 穿孔(3.7±1.1 比 3.5±1.0,p=0.029)评分更高。Carlino 病例的手术和透视时间较长,造影剂用量和辐射剂量较高。Carlino 病例的技术成功率(65.6%比 78.5%,p<0.001)和手术成功率(63.3%比 76.3%,p<0.001)较低,主要不良心脏事件发生率(6.2%比 3.2%,p=0.101)和心包穿刺术(3.9%比 1.3%,p=0.042)、穿孔(18.0%比 8.9%,p=0.001)和对比剂诱导的急性肾损伤(2.3%比 0.4%,p=0.012)发生率较高。逆行交叉时使用 Carlino 技术与更高的手术成功率相关(81.5%比 58.4%,p=0.047)。Carlino 技术越来越多地用于 CTO PCI,特别是用于更高复杂性病变。

相似文献

1
Use of the Carlino Technique in Chronic Total Occlusion Percutaneous Coronary Intervention.卡洛尼技术在慢性完全闭塞经皮冠状动脉介入治疗中的应用。
Am J Cardiol. 2023 Nov 15;207:305-313. doi: 10.1016/j.amjcard.2023.08.155. Epub 2023 Sep 28.
2
Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention.逆行卡尔利诺技术在慢性完全闭塞性经皮冠状动脉介入治疗中的作用。
Catheter Cardiovasc Interv. 2023 Feb;101(3):563-568. doi: 10.1002/ccd.30565. Epub 2023 Jan 22.
3
Geographic diversity in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-CTO registry.慢性完全闭塞经皮冠状动脉介入治疗的地域差异:来自 PROGRESS-CTO 注册研究的见解。
J Invasive Cardiol. 2024 Sep;36(9). doi: 10.25270/jic/24.00056.
4
Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.球囊辅助的次内膜下入路(BASE)在慢性完全闭塞经皮冠状动脉介入治疗中的应用。
Catheter Cardiovasc Interv. 2023 Nov;102(5):834-843. doi: 10.1002/ccd.30830. Epub 2023 Sep 7.
5
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft.逆行慢性完全闭塞经皮冠状动脉介入治疗通过隐静脉桥。
JACC Cardiovasc Interv. 2020 Feb 24;13(4):517-526. doi: 10.1016/j.jcin.2019.10.028.
6
In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure.在同一手术过程中通过经皮介入尝试处理多于一处慢性完全性冠状动脉闭塞的院内结局。
Am J Cardiol. 2018 Aug 1;122(3):381-387. doi: 10.1016/j.amjcard.2018.04.021. Epub 2018 May 1.
7
Lesion characteristics and procedural outcomes of re-attempted percutaneous coronary interventions for chronic total occlusion.慢性完全闭塞病变再次尝试经皮冠状动脉介入治疗的病变特征及手术结果
Heart Vessels. 2018 Jun;33(6):573-582. doi: 10.1007/s00380-017-1091-3. Epub 2017 Dec 9.
8
A Systematic Review of Periprocedural Risk Prediction Scores in Chronic Total Occlusion Percutaneous Coronary Intervention.慢性完全闭塞经皮冠状动脉介入治疗围手术期风险预测评分的系统评价
Am J Cardiol. 2023 Apr 15;193:118-125. doi: 10.1016/j.amjcard.2023.01.044. Epub 2023 Mar 9.
9
Impact of calcium on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention.钙对慢性完全闭塞经皮冠状动脉介入治疗的程序技术和结果的影响。
Int J Cardiol. 2023 Nov 1;390:131254. doi: 10.1016/j.ijcard.2023.131254. Epub 2023 Aug 9.
10
Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.性别差异在慢性完全闭塞经皮冠状动脉介入治疗中的作用:来自 PROGRESS-CTO 注册研究的启示。
Catheter Cardiovasc Interv. 2022 Nov;100(6):1010-1018. doi: 10.1002/ccd.30425. Epub 2022 Oct 25.

引用本文的文献

1
HydroDynamic contrast recanalization (HDR): a new weapon against an old enemy: a case study describing a novel chronic total occlusion treatment technique.流体动力学造影再通术(HDR):对抗旧敌的新武器:一项描述新型慢性完全闭塞治疗技术的病例研究
Postepy Kardiol Interwencyjnej. 2025 May 30;21(2):255-258. doi: 10.5114/aic.2025.151698. eCollection 2025 Jun.